Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 2022

View Archived Issues

Accumulation of aberrant acylation PTMs on critical metabolic enzymes underlies MMA

Q-griffithsin: an antiviral lectin for COVID-19

Vanderbilt University patents new muscarinic M4 receptor antagonists

Deciphera Pharmaceuticals discloses PERK and/or GCN2 inhibitors

Beijing Jacobio Pharmaceuticals identifies new GTPase KRAS inhibitors

A&J Science synthesizes new antibacterials

National Center for Geriatrics & Gerontology synthesizes acyclic retinoid derivatives

Aqilion receives clearance for phase I study of AQ-280 for eosinophilic esophagitis

ADGRL1 haploinsufficiency linked to neurodevelopmental disorders

T3SS inhibitor MBX-5452 well tolerated and reduces bacterial load in pneumonia mouse model

Merck KGaA collaborates with University of Bonn on tools for computational chemistry modeling

Gain-of-function p.Glu1099Lys variant in the NSD2 gene tied to novel syndrome

Scientists discover new mechanism that causes cardiac hypertrophy in response to pressure overload

Variants in the FOSL2 gene cause a new neurodevelopmental disorder

TAMM41 gene variation associated with neonatal mitochondrial disease

Omega Therapeutics files IND for OTX-2002 for HCC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...